# FDA Inspection 1165273 - AndersonBrecon Inc - March 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/ce26bcf2-0c6e-47b0-984f-1d1cb7460768
Source feed: FDA_Inspections

> FDA Inspection 1165273 for AndersonBrecon Inc on March 04, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1165273
- Company Name: AndersonBrecon Inc
- Inspection Date: 2022-03-04
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 947995 - 2015-10-16](https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/3c37ec34-41b7-478b-a86a-3cad0c096c18)
- [FDA Inspection 584572 - 2009-04-15](https://www.keypedia.com/records/fda_inspections/andersonbrecon-inc/6be246db-6f18-4a7e-8377-98e5e5391d58)

Company: https://www.keypedia.com/companies/andersonbrecon-inc/dff37f36-2fc0-4198-afd7-dd318b1bf434

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c